Myomo (MYO) Net Margin Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,501.00 |
| Jun 30, 2025 | 3,111.00 |
| Mar 31, 2025 | 3,753.00 |
| Dec 31, 2024 | 13,806.00 |
| Sep 30, 2024 | 3,643.00 |
| Jun 30, 2024 | 6,953.00 |
| Mar 31, 2024 | 2,456.00 |
| Dec 31, 2023 | 17,636.00 |
| Sep 30, 2023 | 10,417.00 |
| Jun 30, 2023 | 36,581.00 |
| Mar 31, 2023 | 36,693.00 |
| Dec 31, 2022 | 12,349.00 |
| Sep 30, 2022 | 38,831.00 |
| Jun 30, 2022 | 21,230.00 |
| Mar 31, 2022 | 33,631.00 |
| Dec 31, 2021 | 21,894.00 |
| Sep 30, 2021 | 38,820.00 |
| Jun 30, 2021 | 33,139.00 |
| Mar 31, 2021 | 62,218.00 |
| Dec 31, 2020 | 240,273.00 |
| Sep 30, 2020 | 11,358.00 |
| Jun 30, 2020 | 214,570.00 |
| Mar 31, 2020 | 899,126.00 |
| Dec 31, 2019 | 13,172.00 |
| Sep 30, 2019 | 19,780.00 |
| Jun 30, 2019 | 8,281.00 |